Urinary Tract, Sexual Organs, and Pregnancy Conditions  >>  Avastin (bevacizumab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

16 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Avastin (bevacizumab) / Roche
NCT01441388: A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.

Withdrawn
1b
0
US
Crizotinib plus VEGF inhibitor combinations, Crizotinib plus axitinib, Crizotinib plus sunitinib, Crizotinib plus bevacizumab, Crizotinib plus sorafenib
Pfizer
Carcinoma, Renal Cell, Glioblastoma, Carcinoma, Hepatocellular
11/13
11/13
NCT01625936: CRLX101 Plus Bevacizumab in Advanced RCC

Checkmark ASCO 2015
Jun 2015 - Jun 2015: ASCO 2015
Checkmark Interim analysis in combination with Avastin
Mar 2015 - Mar 2015: Interim analysis in combination with Avastin
Checkmark ASCO 2014
More
Completed
1b
22
US
CRLX101 (Cerulean), Bevacizumab
Abramson Cancer Center of the University of Pennsylvania
Renal Cell Carcinoma
07/17
07/18
NCT00421512: A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients

Completed
1
28
US
Bevacizumab and Sunitinib
Memorial Sloan Kettering Cancer Center
Metastatic Renal Cell Carcinoma, Kidney Cancer
05/08
05/08
NCT00683241: A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer

Completed
1
36
US
DCVac-L
Abramson Cancer Center of the University of Pennsylvania, Northwest Biotherapeutics, University of California, San Francisco
Ovarian Cancer, Peritoneal Cancer
12/09
12/09
NCT01202890: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer

Terminated
1
1
US
Lenalidomide, Liposomal Doxorubicin, Bevacizumab, Revlimid, Doxil, Avastin
New Mexico Cancer Care Alliance, Celgene Corporation
Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma
05/11
05/12
NCT01219777: Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian

Completed
1
9
US
carboplatin, Paraplatin®, CBDCA, Bevacizumab, Avastin, Paclitaxel, Taxol, Abraxane
Ritu Salani, Genentech, Inc.
Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer
05/12
05/15
PARASOL, NCT01202032: Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors

Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Checkmark P1 data-ASCO
Jun 2012 - Jun 2012: P1 data-ASCO
Completed
1
36
Europe
Association of Bevacizumab (BVC)+ Pazopanib (PZP)
Centre Leon Berard
Metastatic Renal Cell Carcinoma, Advanced Refractory Solid Tumors Histologically or Cytologically Confirmed
01/13
03/13
NCT00992121: An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma

Completed
1
11
Europe
Bevacizumab, Pazopanib 2 week, Pazopanib 3 week
GlaxoSmithKline
Carcinoma, Renal Cell
11/13
11/13
NCT01243359: Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies

Checkmark ASCO-GU 2013
Feb 2013 - Feb 2013: ASCO-GU 2013
Completed
1
6
US
sunitinib malate, SU11248, sunitinib, Sutent, bevacizumab, anti-VEGF humanized monoclonal antibody, anti-VEGF monoclonal antibody, Avastin, rhuMAb VEGF, pharmacological study, pharmacological studies, laboratory biomarker analysis, fluorine F 18 fluorothymidine, 18F-FLT, 3'-deoxy-3'-[18F]fluorothymidine, fluorothymidine F-18, positron emission tomography, FDG-PET, PET, PET scan, tomography, emission computed, computed tomography, tomography, computed
National Cancer Institute (NCI)
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Unspecified Adult Solid Tumor, Protocol Specific
02/14
 
CHIPASTIN, NCT02217956: Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma

Completed
1
30
Europe
Cisplatin, Bevacizumab
Gustave Roussy, Cancer Campus, Grand Paris
Ovarian Adenocarcinoma, Fallopian Tube Adenocarcinoma, Primary Peritoneal Carcinoma
06/15
06/15
NCT01248949: A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors

Checkmark Of P1 trial for solid tumours and ovarian cancer
Feb 2017 - Feb 2017: Of P1 trial for solid tumours and ovarian cancer
Completed
1
162
US
MEDI3617, Bevacizumab, Paclitaxel, Carboplatin
MedImmune LLC
Advanced Solid Tumors, Advanced Recurrent Ovarian Tumors
07/15
10/15
NCT01183663: Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Checkmark Lenalidomide in combination with temsirolimus in pts with adv cancer
Aug 2013 - Aug 2013: Lenalidomide in combination with temsirolimus in pts with adv cancer
Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Checkmark Data-AACR
More
Completed
1
180
US
Lenalidomide, CC-5013, Revlimid, Bevacizumab, Avastin, Anti-VEGF monoclonal antibody, rhuMAB-VEGF, Sorafenib, Nexavar, BAY 43-90006, Temsirolimus, CC-779, Torisel, Oxaliplatin, Eloxatin, Leucovorin, Citrovorum, Wellcovorin, 5-fluorouracil, 5-FU, Adrucil, Efudex
M.D. Anderson Cancer Center, Celgene
Advanced Cancers
05/16
05/16
NCT01283048: Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Completed
1
32
US
BKM-120 Bevacizumab, Avastin
Toni Choueiri, MD, Beth Israel Deaconess Medical Center
Renal Cell Carcinoma
09/16
09/16
NCT01995188: A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer

Completed
1
41
US
Bevacizumab, Avastin, Carboplatin, DNIB0600A
Genentech, Inc.
Non-Squamous Non-Small Cell Lung Cancer
11/16
11/16
NCT02835833: Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors

Completed
1
21
US
Nintedanib, BIBF1120, Bevacizumab, Avastin
University of Alabama at Birmingham, Boehringer Ingelheim
Renal Cell Carcinoma, Colorectal Adenocarcinoma, Non-squamous Non-small Cell Lung Cancer, Platinum-refractory Ovarian Carcinoma, Cervical Carcinoma
04/18
06/18
NCT01132014: Autologous OC-DC Vaccine in Ovarian Cancer

Completed
1
67
US
OCDC
Abramson Cancer Center of the University of Pennsylvania
Chemotherapy, Tumor, Ovarian Cancer
05/18
05/18

Download Options